[Federal Register Volume 84, Number 40 (Thursday, February 28, 2019)]
[Notices]
[Page 6824]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03540]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 28, 2019, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Worcester Polytechnic Institute, 
Worcester, MA; Odyssey Systems Consulting Group, Ltd., Wakefiled, MA; 
Serpin Pharma, Nokesville, VA; Csymplicity Software Solutions, Inc., 
Allentown, PA; Qrons, Inc., Miami, FL; Intelligent Optical Systems, 
Inc., Torrance, CA; Abfero Pharmaceuticals Inc., Boston, MA; Shamrock 
Medical LLC, Phoenix, AZ; Sleep Care, Inc., Columbus, OH; Solution 
Guidance Corporation, Chantilly, VA; Existential Technologies, Inc., 
Chula Vista, CA; Bionica Labs LLC, Richmond, VA; Acell, Inc., Columbia, 
MD; Awarables Inc., Baltimore, MD; Onera BV, AB Eindhoven, THE 
NETHERLANDS; Healios, Inc., Flemington, NJ; Sanofi Pasteur, Swiftwater, 
PA; Biobeat Technologies Ltd., Petach Tikva, ISRAEL; Sana Health, Inc., 
San Anselmo, CA; ThoraXS Israel 17 Ltd, Tzur hadassa, ISRAEL; ADM 
Tronics Unlimited, Inc., Northvale, NJ; Aktivax, Inc., Broomfield, CO; 
XSurgical, Inc., Ipswich, MA; 98point6 Inc., Seattle, WA; University of 
Montana, Missoula, MT; Engility Corporation, Chantilly, VA; Entasis 
Therapeutics, Waltham, MA; Thomas Jefferson University, Philadelphia, 
PA; Gryphon Bio, Inc., South San Francisco, CA; Arcos, Inc., and 
Missouri City, TX; have been added as parties to this venture.
    Also, Actuated Medical, Inc., Bellefonte, PA; Disarm Therapeutics, 
Inc., Cambridge, MA; Global Virus Network, Inc., Baltimore, MD; Health 
Research, Inc.--Wadsworth Center, Menands, NY; Parsons Government 
Services Inc., Pasadena, CA; Perceptronics Solutions, Inc., Sherman 
Oaks, CA; Tallinn University of Technology, Tallin, ESTONIA; The 
Regents of the University of Michigan, Ann Arbor, MI; and The 
Washington University, St. Louis, MO; have withdrawn as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on October 12, 
2018. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 2, 2018 (83 FR 55204).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-03540 Filed 2-27-19; 8:45 am]
BILLING CODE 4410-11-P